After witnessing a 95 %
decline in the pharmaceutical company's share price amid a series of scandals, Valeant's board, led by former shareholder and hedge fund manager Bill Ackman, smartly tied Papa's compensation to a recovery in the stock price.
In the 1920s food corporations and
pharmaceutical companies developed and marketed a second generation of commercial infant formulas, the availability of which contributed further to the
decline and duration of breastfeeding.